American Custom Technologies produces topical patches with the following over-the-counter medications:
- Lidocaine (pain patches)
- Menthol (cooling patches)
- Capsacin (heating patches)
- Methyl Salicylate (cooling patches)
- Salicylic Acid (acne patches)
- Hydrocortisone (steroid patches)
We manufacture our patches in an FDA-registered facility, and are experienced in producing over-the-counter patches to our customers’ specifications.
Special Notice about Combinations:
American Custom Technologies, as a custom contract manufacturer, is often requested to produce topical patches which are a combination of already-FDA-monographed drugs and new ingredients.
**We would be delighted to produce your OTC drugs in compliance with FDA monograph regulations.**
We will not produce products which we know are likely to be subject to FDA compliance actions – including recalls and fines. We cannot do so in good conscience. We know that other manufacturers do so – but we pride ourselves in the quality of our work, and we are, as an FDA registered facility, subject to FDA audits.
When we have inquired directly with the FDA about these combinations, this is the response we received:
“Please be aware that one of the factors that are considered when reviewing a product to determine whether it is a drug is by the intended use, an example of this is ingredients that cause a product to be considered a drug because they have a well-known (to the public and industry) therapeutic use.
Though the product may not be labeled specifically stating a certain use, this product would appear to be a drug product and must comply with FDA drug regulations.
The manufacture or marketing of unapproved drugs in the U.S. is subject to FDA compliance actions. “
Some of our most commonly requested FDA monographed OTC drugs are: Menthol, Capsaicin, Wintergreen (aka Methyl Salicitate), Lidocaine, and Camphor. We are an FDA registered facility, and we would be happy to manufacture products which are in compliance with the current FDA monograph regulations.
We recommend that our customers who are interested in producing products combining already monographed drugs and other active ingredients begin the process of a New Drug Application – including investing in experienced legal representation.